SCHEMBL4285618

SCHEMBL4285618

COc1ccc(C(O)c2c(O)cccc2Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 2/20 0.43
GAA P10253 2/20 0.43
ALDH1A1 P00352 3/20 0.39
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
RELA Q04206 1/20 0.38
ATM Q13315 1/20 0.37
ACP3 P15309 1/20 0.37
AOC3 Q16853 1/20 0.37
AHR P35869 1/20 0.37
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4288652 0.80 MEN1 (0.45) KMT2AMEN1TSHRMAPK1GAA
SCHEMBL23663329 0.76 MEN1 (0.49) KMT2AMEN1TSHRMAPK1GAA
SCHEMBL29256762 0.75 CYP3A4 (0.48) KMT2AMEN1TSHRMAPK1GAA
SCHEMBL23663342 0.74 MEN1 (0.48) KMT2AMEN1TSHRMAPK1GAA
SCHEMBL14181097 0.73 TSHR (0.47) TSHRMAPK1GAAALDH1A1L3MBTL1
SCHEMBL120187 0.73 CA12 (0.58) TSHRMAPK1GAAALDH1A1TDP1
SCHEMBL1349310 0.72 GAA (0.55) KMT2AMEN1TSHRMAPK1GAA
SCHEMBL4287172 0.71 NPBWR1 (0.41) KMT2AMEN1MAPK1ALDH1A1RELA
SCHEMBL5691021 0.70 LTA4H (0.61) KMT2AMEN1GAAALDH1A1AOC3
SCHEMBL477389 0.70 ACP3 (0.61) KMT2ATSHRMAPK1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 KMT2A 1397/4885MEN1 3776/4885TSHR 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.